← back to search

Saleh A. Alqahtani

Cornell University · US
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Hepatitis C virus research, and Organ Transplantation Techniques and Outcomes.
h-index
55
citations
12,089
works
432
NIH funding
primary concept
Medicine
email

Recent publications

Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study
Nature Medicine 2026cited by 0position: middledoi
Underrepresentation of Arabs in Functional Genetics Studies: Opportunities and Obstacles for Advancing Biology and Human Health
Liver International 2025cited by 10position: middledoi
Adverse Liver and Renal Outcomes After Initiating <scp>SGLT</scp>‐2i and <scp>GLP</scp>‐<scp>1RA</scp> Therapy Among Patients With Diabetes and <scp>MASLD</scp>
Journal of Diabetes 2025cited by 7position: lastdoi
“Weekend Warrior” Exercise Pattern Protects Against <scp>MASLD</scp> and Mortality Comparable to Regular Exercise: National Cohort Study
Liver International 2025cited by 7position: middledoi
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study
Hepatology 2025cited by 6position: middledoi
Steatotic liver disease is the dominant indication for liver transplantation in both Europe and the United States: Trends and outcomes in the past 2 decades
Liver Transplantation 2025cited by 6position: middledoi
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
Journal of Hepatology 2024cited by 276position: middledoi
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Med 2024cited by 50position: middledoi
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
JHEP Reports 2024cited by 29position: middledoi
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease
Science Translational Medicine 2024cited by 28position: middledoi
MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight
Therapeutic Advances in Endocrinology and Metabolism 2024cited by 23position: middledoi
The current and future cancer burden in the Gulf Cooperation Council (<scp>GCC</scp>) countries
Cancer Medicine 2024cited by 22position: middledoi
The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia
Saudi Journal of Gastroenterology 2024cited by 18position: firstdoi
Cancer Research Challenges and Potential Solutions in Saudi Arabia: A Qualitative Discussion Group Study
JCO Global Oncology 2024cited by 11position: lastdoi
Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosis
Scientific Reports 2024cited by 2position: middledoi
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Hepatology International 2023cited by 180position: middledoi
Acute Liver Failure Guidelines
The American Journal of Gastroenterology 2023cited by 178position: middledoi
The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019
Hepatology Communications 2023cited by 165position: middledoi
A global research priority agenda to advance public health responses to fatty liver disease
Journal of Hepatology 2023cited by 128position: middledoi
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
JAMA Network Open 2023cited by 105position: middledoi
Consensus Statement on the definition and classification of metabolic hyperferritinaemia
Nature Reviews Endocrinology 2023cited by 97position: middledoi
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
Journal of Hepatology 2023cited by 94position: middledoi
A global action agenda for turning the tide on fatty liver disease
Hepatology 2023cited by 83position: middledoi
Implementation of a liver health check in people with type 2 diabetes
˜The œLancet. Gastroenterology & hepatology 2023cited by 59position: middledoi
The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories
Hepatology 2023cited by 26position: middledoi
Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic review
European Journal of Clinical Nutrition 2023cited by 7position: lastdoi
Prevalence, risk factors, and interventions for obesity in Saudi Arabia: A systematic review
Obesity Reviews 2022cited by 137position: lastdoi
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative
PLoS Genetics 2022cited by 65position: middledoi
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients
Hepatology Communications 2022cited by 59position: middledoi
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
JHEP Reports 2022cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ziad A. Memish · King Abdullah International Medical Research Center10 papers (2020–2021)Zobair M. Younossi · NIHR Birmingham Biomedical Research Centre9 papers (2020–2025)Jörn M. Schattenberg · Universitätsklinikum des Saarlandes7 papers (2020–2024)Linda Henry · Center for Outcomes Research in Liver Diseases6 papers (2020–2025)James M. Paik · Inova Health System5 papers (2021–2025) · 4 papers (2020–2021)Dimitrios Karakitsos · University of South Carolina4 papers (2020–2021)Janus P. Ong · University of the Philippines Manila4 papers (2020–2024) · 4 papers (2020–2021)Ziyan Pan · Shihezi University3 papers (2024–2025)Yusuf Ahmed · Sunnybrook Health Science Centre3 papers (2020–2020)Christian Labenz · Saarland University3 papers (2021–2024) · 3 papers (2020–2023) · 3 papers (2020–2021)Peter R. Galle · University of Lübeck3 papers (2021–2024)Maria Stepanova · Zen-Noh (Japan)3 papers (2020–2024)Hani Tamim · McMaster University2 papers (2020–2021) · 2 papers (2022–2024)Patrizia Burra · Network Group (Czechia)2 papers (2022–2025)Shira Zelber‐Sagi · Tel Aviv University2 papers (2023–2025)